MYND Life Sciences Inc. (MYND.CN)
CAD 0.07
(-30.0%)
CAD 0.07
(-30.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.03 CAD | 57.98% |
| 2022 | -0.08 CAD | 21.32% |
| 2021 | -0.10 CAD | -4755.0% |
| 2020 | -0.00 CAD | -33.33% |
| 2019 | -0.00 CAD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.01 CAD | 29.11% |
| 2024 Q1 | -0.01 CAD | -180.61% |
| 2024 Q3 | -0.01 CAD | -46.43% |
| 2023 Q4 | 0.01 CAD | 186.73% |
| 2023 Q2 | -0.01 CAD | 40.63% |
| 2023 Q1 | -0.02 CAD | -89.83% |
| 2023 FY | - CAD | 57.98% |
| 2023 Q3 | -0.01 CAD | 15.04% |
| 2022 Q3 | -0.02 CAD | -0.46% |
| 2022 Q2 | -0.02 CAD | 23.16% |
| 2022 Q1 | -0.03 CAD | 14.93% |
| 2022 FY | - CAD | 21.32% |
| 2022 Q4 | -0.01 CAD | 46.36% |
| 2021 Q3 | -0.02 CAD | -11.83% |
| 2021 FY | - CAD | -4755.0% |
| 2021 Q2 | -0.02 CAD | 34.75% |
| 2021 Q4 | -0.03 CAD | -77.25% |
| 2021 Q1 | -0.03 CAD | 0.0% |
| 2020 FY | - CAD | -33.33% |
| 2019 FY | - CAD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Algernon Pharmaceuticals Inc. | -0.45 CAD | 92.867% |
| Asep Medical Holdings Inc | -0.13 CAD | 75.308% |
| BetterLife Pharma Inc. | -0.03 CAD | -21.591% |
| BioVaxys Technology Corp. | -0.06 CAD | 43.979% |
| ChitogenX Inc. | -0.02 CAD | -50.704% |
| Rapid Dose Therapeutics Corp. | -0.04 CAD | 21.707% |
| Defence Therapeutics Inc. | -0.30 CAD | 89.3% |
| Entheon Biomedical Corp. | -0.05 CAD | 36.811% |
| Gemina Laboratories Ltd. | -0.07 CAD | 55.417% |
| Glow Lifetech Corp. | -0.03 CAD | -11.458% |
| Lexston Life Sciences Corp. | -0.02 CAD | -39.565% |
| Pharmala Biotech Holdings Inc. | -0.01 CAD | -248.913% |
| Doseology Sciences Inc. | -0.08 CAD | 59.724% |
| Nova Mentis Life Science Corp. | -0.01 CAD | -286.747% |
| PharmaTher Holdings Ltd. | -0.04 CAD | 9.065% |
| PreveCeutical Medical Inc. | -0.00 CAD | -1237.5% |
| Telescope Innovations Corp. | -0.12 CAD | 73.25% |